India suspends export of vaccines, Kosovo could be affected

Officials from this ministry said that increasing the number of cases means that demand for vaccines within the country may increase over the coming weeks, so doses will be needed for the vaccine programme in India.

This decision is expected to affect the remittances of doses to other countries planned by the end of April, while this will affect delays in some 190 countries supplied by the COVAX programme, the BBC reports, broadcasting Express.

The COVAX programme, led by the World Health Organization, aims to ensure fair distribution of vaccines in all countries.

With this vaccine, which will be produced by the “Serum” in India, Kosovo is expected to be supplied, but it is not known when exactly the first doses will reach. These doses in Kosovo are expected to arrive as part of the COVAX programme.

The largest Indian vaccine producer, the Serum Institute, has postponed sending AstraZeneca vaccines to several states recently, including Great Britain and Brazil.

So far, India has exported more than 60 million doses of vaccines to 76 countries. Most of these doses were from the company's vaccine “AstraZeneca”, which was suspended for a period in several European states due to concerns about blood clotting in vaccinated persons.